DocGo Begin Period Cash Flow from 2010 to 2024

DCGO Stock  USD 4.20  0.04  0.94%   
DocGo Begin Period Cash Flow yearly trend continues to be very stable with very little volatility. Begin Period Cash Flow is likely to drop to about 97.3 M. Begin Period Cash Flow is the amount of cash DocGo Inc has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
164.1 M
Current Value
97.3 M
Quarterly Volatility
56.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check DocGo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DocGo's main balance sheet or income statement drivers, such as Tax Provision of 6.6 M, Net Interest Income of 1.8 M or Depreciation And Amortization of 9.7 M, as well as many indicators such as Price To Sales Ratio of 0.88, Dividend Yield of 0.0 or PTB Ratio of 1.83. DocGo financial statements analysis is a perfect complement when working with DocGo Valuation or Volatility modules.
  
Check out the analysis of DocGo Correlation against competitors.

Latest DocGo's Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of DocGo Inc over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. DocGo's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DocGo's overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Slightly volatile
   Begin Period Cash Flow   
       Timeline  

DocGo Begin Period Cash Flow Regression Statistics

Arithmetic Mean43,685,167
Geometric Mean24,351,434
Coefficient Of Variation130.32
Mean Deviation42,339,515
Median12,853,320
Standard Deviation56,928,644
Sample Variance3240.9T
Range166.3M
R-Value0.71
Mean Square Error1727.3T
R-Squared0.51
Significance0
Slope9,046,835
Total Sum of Squares45372.2T

DocGo Begin Period Cash Flow History

202497.3 M
2023164.1 M
2022179.1 M
202134.5 M
202051.8 M

About DocGo Financial Statements

DocGo investors utilize fundamental indicators, such as Begin Period Cash Flow, to predict how DocGo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Begin Period Cash Flow164.1 M97.3 M

Pair Trading with DocGo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DocGo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocGo will appreciate offsetting losses from the drop in the long position's value.

Moving together with DocGo Stock

  0.94GH Guardant Health Buyout TrendPairCorr
  0.9LH LaboratoryPairCorr

Moving against DocGo Stock

  0.8DRIO DarioHealth CorpPairCorr
  0.76EKSO Ekso Bionics HoldingsPairCorr
  0.58VERO Venus ConceptPairCorr
  0.57FLGT Fulgent GeneticsPairCorr
  0.5FEMY FemasysPairCorr
The ability to find closely correlated positions to DocGo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DocGo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DocGo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DocGo Inc to buy it.
The correlation of DocGo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DocGo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DocGo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DocGo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DocGo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DocGo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Docgo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Docgo Inc Stock:
Check out the analysis of DocGo Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.09
Earnings Share
0.29
Revenue Per Share
6.752
Quarterly Revenue Growth
(0.26)
Return On Assets
0.0658
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.